1,270
Views
8
CrossRef citations to date
0
Altmetric
Articles

Fabrication and evaluation of nanoparticle-assembled BSA microparticles for enhanced liver delivery of glycyrrhetinic acid

, , , , , & show all
Pages 740-747 | Received 09 Apr 2016, Accepted 19 May 2016, Published online: 07 Jun 2016

References

  • Bera H, Boddupalli S, Nayak AK. 2015. Mucoadhesive-floating zinc-pectinate-sterculia gum interpenetrating polymer network beads encapsulating ziprasidone HCl. Carbohydr Polym. 131:108–118.
  • Birnbaum DT, Kosmala JD, Henthorn DB, Brannon-Peppas L. 2000. Controlled release of beta-estradiol from PLAGA microparticles: the effect of organic phase solvent on encapsulation and release. J Control Release. 65:375–387.
  • Chorny M, Fishbein I, Danenberg HD, Golomb G. 2002. Lipophilic drug loaded nanospheres prepared by nanoprecipitation: effect of formulation variables on size, drug recovery and release kinetics. J Control Release. 83:389–400.
  • Ci Y, Wang L, Guo Y, Sun R, Wang X, Li J. 2015. Study on encapsulation of chlorine dioxide in gelatin microsphere for reducing release rate. Int J Clin Exp Med. 8:12404–12410.
  • Das S, Ng KY, Ho PC. 2011. Design of pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations. J Drug Target. 19:446–457.
  • D'Mello SR, Yoo J, Bowden NB, Salem AK. 2014. Microparticles prepared from sulfenamide-based polymers. J Microencapsul. 31:137–146.
  • Elzoghby AO, Samy WM, Elgindy NA. 2012. Albumin-based nanoparticles as potential controlled release drug delivery systems. J Control Release. 157:168–182.
  • Guo BH, Cheng Y, Lin LP. 2010. Preparation and pharmaceutical characterization of glycyrrhetinic acid liposomes. Chin Trad Herb Drug. 41:380–383.
  • Guo BH, Cheng Y, Wu W, Lin LP, Lin DH. 2012. HPLC assay and pharmacokinetics and tissue distribution study of glycyrrhetinic acid liposomes modified with galactosylated lipid. J Liposome Res. 22:120–127.
  • Han TF, Yan JH, Dou JJ, Hui X, Xu K, Chen G, et al. 2012. Study on the preparation technique of glycyrrhetinic acid ethosomes. Northwest Pharmaceut J. 27:64–66.
  • Kouchakzadeh H, Shojaosadati SA, Shokri F. 2014. Efficient loading and entrapment of tamoxifen in human serum albumin based nanoparticulate delivery system by a modified desolvation technique. Chem Eng Res Des. 92:1681–1692.
  • Kwon JH, Lee BH, Lee JJ, Kim CW. 2004. Insulin microcrystal suspension as a long-acting formulation for pulmonary delivery. Eur J Pharm Sci. 22:107–116.
  • Langer K, Balthasar S, Vogel V, Dinauer N, von Briesen H, Schubert D. 2003. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int J Pharm. 257:169–180.
  • Liu D, Xu H, Tian B, Yuan K, Pan H, Ma S, et al. 2012. Fabrication of carvedilol nanosuspensions through the anti-solvent precipitation-ultrasonication method for the improvement of dissolution rate and oral bioavailability. AAPS PharmSciTech. 13:295–304.
  • Liu HQ, Zhang XJ. 2005. Study on the preparation and properties in vitro of fluorouracil albumin sustained release microsphere. Guangdong Chem Ind. 8:37–39.
  • Lu Y, Li J, Wang G. 2008. In vitro and in vivo evaluation of mPEG-PLA modified liposomes loaded glycyrrhetinic acid. Int J Pharm. 356:274–281.
  • Minamimura T, Sato H, Kasaoka S, Saito T, Ishizawa S, Takemori S, et al. 2000. Tumor regression by inductive hyperthermia combined with hepatic embolization using dextran magnetite-incorporated microspheres in rats. Int J Oncol. 16:1153–1158.
  • Norde W, Giacomelli CE. 2000. BSA structural changes during homomolecular exchange between the adsorbed and the dissolved states. J Biotechnol. 79:259–268.
  • Patino T, Soriano J, Barrios L, Ibanez E, Nogues C. 2015. Surface modification of microparticles causes differential uptake responses in normal and tumoral human breast epithelial cells. Sci Rep. 5:1–12.
  • Prabhu S, Jacknowitz AI, Stout PJ. 2001. A study of factors controlling dissolution kinetics of zinc complexed protein suspensions in various ionic species. Int J Pharm. 217:71–78.
  • Pu XH, Sun J, Han JH, Lian H, Zhang P, Yan ZT, et al. 2013. Nanosuspensions of 10-hydroxycamptothecin that can maintain high and extended supersaturation to enhance oral absorption: preparation, characterization and in vitro/in vivo evaluation. J Nanopart Res. 15:1–13.
  • Viúdez A, Ramírez N, Hernández-García I, Carvalho FL, Vera R, Hidalgo M. 2014. Nab-paclitaxel: a flattering facelift. Crit Rev Oncol Hematol. 92:166–180.
  • Wilson B, Ambika TV, Patel RD, Jenita JL, Priyadarshini SR. 2012. Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery. Int J Biol Macromol. 51:874–878.
  • Wang Z, Li Z, Zhang D, Miao L, Huang G. 2015. Development of etoposide-loaded bovine serum albumin nanosuspensions for parenteral delivery. Drug Deliv. 22:79–85.
  • Weber C, Kreuter J, Langer K. 2000. Desolvation process and surface characteristics of HSA nanoparticles. Int J Pharm. 196:197–200.
  • Xing X, Zhang B, Wang X, Liu F, Shi D, Cheng Y. 2015. An “imaging-biopsy” strategy for colorectal tumor reconfirmation by multipurpose paramagnetic quantum dots. Biomaterials. 48:16–25.
  • Zhang B, Wang X, Liu F, Cheng Y, Shi D. 2012. Effective reduction of nonspecific binding by surface engineering of quantum dots with bovine serum albumin for cell-targeted imaging. Langmuir. 28:16605–16613.
  • Zhao K, Ding M, Cao H, Cao ZX. 2012. In-vitro metabolism of glycyrrhetinic acid by human and rat liver microsomes and its interactions with six CYP substrates. J Pharm Pharmacol. 64:1445–1451.
  • Zhao X, Liu J, Hu Y, Fan Y, Wang D, Yuan J, et al. 2012. Optimization on condition of glycyrrhetinic acid liposome by RSM and the research of its immunological activity. Int J Biol Macromol. 51:299–304.
  • Zhong DG, Liu ZH, Huang YC, Shi YF, Zhang Y, Xue W. 2012. Preparation and in vitro release of alginate-carboxymethyl chitosan composite hydrogel beads for 18β-glycyrrhetinic acid delivery. Mater Rev B. 26:77–80.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.